Company Monitoring Page for Regeneron

latest headlines for company on cafepharma

Regeneron to expand development deal with Intellia Therapeutics
Marketwatch
Mon, 06/1/20 - 10:30 am
Tags:
Regeneron, Intellia Therapeutics, hemophilia A, hemophilia B, CRISPR, drug development
What Sanofi Might Buy With Its Regeneron Windfall
Barron's
Wed, 05/27/20 - 11:01 am
Tags:
Sanofi, Regeneron, M&A, gene therapy, Ultragenyx, Bluebird Bio
Sanofi and Regeneron's Dupixent Scores Another Approval for Dermatitis, This Time in Kids
BioSpace
Wed, 05/27/20 - 10:47 am
Tags:
Sanofi, Regeneron, Dupixent, atopic dermatitis, pediatric
Dupixent clears PhIII trial in new disease as blockbuster looks to expand past Regeneron-Sanofi split
Endpoints
Wed, 05/27/20 - 10:27 am
Tags:
Dupixent, Sanofi, Regeneron, esosinophilic esophagitis, EoE, clinical trials
Sanofi to Sell Regeneron Stake Worth About $13 Billion
Yahoo/Bloomberg
Mon, 05/25/20 - 11:32 pm
Tags:
Sanofi, Regeneron
Regeneron CEO: Manufacturing not up to snuff for COVID-19 vaccines, therapies
Fierce Pharma
Tue, 05/12/20 - 11:59 am
Tags:
Regeneron, COVID-19, Kevzara, Pharma CEOs, drug development, vaccines, pandemic, Len Schleifer
Regeneron Says Its COVID-19 Combo Treatment Could Be Ready for People This Fall
Motley Fool
Wed, 05/6/20 - 12:02 pm
Tags:
Regeneron, COVID-19, REGN-COV2, earnings, clinical trials
Regeneron touts Eylea strength as Novartis rival falters, COVID-19 cuts demand
Fierce Pharma
Tue, 05/5/20 - 01:02 pm
Tags:
Regeneron, Eylea, Novartis, Beovu, COVID-19
Sanofi and Regeneron's I-O med Libtayo, on a roll, puts up basal cell carcinoma win
Fierce Pharma
Tue, 05/5/20 - 12:59 pm
Tags:
Sanofi, Regeneron, Libtayo, basal cell carcinoma, skin cancer, clinical trials
While Big Pharma Tanked, Gilead Sciences and Regeneron Soared
Motley Fool
Sat, 04/25/20 - 11:34 pm
Tags:
Big Pharma, Gilead Sciences, Regeneron
Does Regeneron Pharmaceuticals’ Winning Streak Signal Irrational Exuberance?
Motley Fool
Fri, 04/24/20 - 10:59 am
Tags:
Regeneron, Eylea, Dupixent
Sanofi culls pipeline dud, still looking to out-license unwanted later-stage meds
Fierce Biotech
Fri, 04/24/20 - 10:54 am
Tags:
Sanofi, Regeneron, efpeglenatide, type 2 diabetes
20 top recipients of COVID-19 government contracts
Beckers Hospital Review
Thu, 04/23/20 - 10:55 am
Tags:
government contracts, COVID-19, pandemic, JNJ, Moderna Therapeutics, 3M, devices, Regeneron, Hamilton Medical, Royal Philips, ventilators
Regeneron gets FDA priority review for Ebola sibling of COVID-19 prospect
Fierce Biotech
Thu, 04/16/20 - 10:58 am
Tags:
Regeneron, REGN-EB3, Ebola, FDA, ZMapp
Aslan's Dupixent rival test put on hold amid COVID-19, but delays shouldn't hit readout
Fierce Biotech
Mon, 04/13/20 - 10:57 am
Tags:
Aslan Pharma, ASLAN004, Regeneron, Sanofi, Dupixent, atopic dermatitis
5 Biotech Stocks Winning the Coronavirus Race
Motley Fool
Sat, 04/11/20 - 10:52 pm
Tags:
COVID-19, pandemic, drug development, Regeneron, Kevzara, Gilead Sciences, remdesivir, Inovio, INO-4800, vaccines, Moderna Therapeutics, mRNA-1273, Novavax, NVX-CoV2373
Data for Regeneron arthritis drug in coronavirus could come in weeks
Stat
Fri, 04/10/20 - 10:41 am
Tags:
Regeneron, COVID-19, Kevzara, clinical trials
With Kevzara in COVID-19 testing, Sanofi and Regeneron won't divvy up their rights
Fierce Pharma
Wed, 04/8/20 - 11:38 pm
Tags:
Sanofi, Regeneron, Paul Hudson, Kevzara, COVID-19
Regeneron and Sanofi Treat First Person Outside U.S. in Coronavirus-Drug Trial
TheStreet.com
Mon, 03/30/20 - 10:31 am
Tags:
Regeneron, Sanofi, clinical trials, COVID-19, Kevzara
Why Is Everyone Talking About Regeneron?
Motley Fool
Mon, 03/23/20 - 11:31 pm
Tags:
Regeneron, COVID-19, Google searches, Sanofi, Kevzara

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.